These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31293697)

  • 1. 2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
    Stiles MK; Fauchier L; Morillo CA; Wilkoff BL
    J Arrhythm; 2019 Jun; 35(3):485-493. PubMed ID: 31293697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
    Stiles MK; Fauchier L; Morillo CA; Wilkoff BL
    J Interv Card Electrophysiol; 2020 Oct; 59(1):135-144. PubMed ID: 31960345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
    Stiles MK; Fauchier L; Morillo CA; Wilkoff BL
    Heart Rhythm; 2020 Jan; 17(1):e220-e228. PubMed ID: 31103461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
    Stiles MK; Fauchier L; Morillo CA; Wilkoff BL;
    Europace; 2019 Sep; 21(9):1442-1443. PubMed ID: 31090914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
    Wilkoff BL; Fauchier L; Stiles MK; Morillo CA; Al-Khatib SM; Almendral J; Aguinaga L; Berger RD; Cuesta A; Daubert JP; Dubner S; Ellenbogen KA; Estes NA; Fenelon G; Garcia FC; Gasparini M; Haines DE; Healey JS; Hurtwitz JL; Keegan R; Kolb C; Kuck KH; Marinskis G; Martinelli M; McGuire M; Molina LG; Okumura K; Proclemer A; Russo AM; Singh JP; Swerdlow CD; Teo WS; Uribe W; Viskin S; Wang CC; Zhang S
    J Arrhythm; 2016 Feb; 32(1):1-28. PubMed ID: 26949427
    [No Abstract]   [Full Text] [Related]  

  • 6. Programming implantable cardioverter-defibrillator in primary prevention: Guideline concordance and outcomes.
    Ananwattanasuk T; Tanawuttiwat T; Chokesuwattanaskul R; Lathkar-Pradhan S; Barham W; Oral H; Thakur RK; Jongnarangsin K
    Heart Rhythm; 2020 Jul; 17(7):1101-1106. PubMed ID: 32058014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients: Developed in collaboration with and endorsed by the Heart Rhythm Society (HRS), the American College of Cardiology (ACC), the American Heart Association (AHA), and the Association for European Paediatric and Congenital Cardiology (AEPC) Endorsed by the Asia Pacific Heart Rhythm Society (APHRS), the Indian Heart Rhythm Society (IHRS), and the Latin American Heart Rhythm Society (LAHRS).
    ; Shah MJ; Silka MJ; Silva JNA; Balaji S; Beach CM; Benjamin MN; Berul CI; Cannon B; Cecchin F; Cohen MI; Dalal AS; Dechert BE; Foster A; Gebauer R; Gonzalez Corcia MC; Kannankeril PJ; Karpawich PP; Kim JJ; Krishna MR; Kubuš P; LaPage MJ; Mah DY; Malloy-Walton L; Miyazaki A; Motonaga KS; Niu MC; Olen M; Paul T; Rosenthal E; Saarel EV; Silvetti MS; Stephenson EA; Tan RB; Triedman J; Bergen NHV; Wackel PL
    JACC Clin Electrophysiol; 2021 Nov; 7(11):1437-1472. PubMed ID: 34794667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
    Wilkoff BL; Fauchier L; Stiles MK; Morillo CA; Al-Khatib SM; Almendral J; Aguinaga L; Berger RD; Cuesta A; Daubert JP; Dubner S; Ellenbogen KA; Mark Estes NA; Fenelon G; Garcia FC; Gasparini M; Haines DE; Healey JS; Hurtwitz JL; Keegan R; Kolb C; Kuck KH; Marinskis G; Martinelli M; McGuire M; Molina LG; Okumura K; Proclemer A; Russo AM; Singh JP; Swerdlow CD; Teo WS; Uribe W; Viskin S; Wang CC; Zhang S
    Heart Rhythm; 2016 Feb; 13(2):e50-86. PubMed ID: 26607062
    [No Abstract]   [Full Text] [Related]  

  • 9. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
    Wilkoff BL; Fauchier L; Stiles MK; Morillo CA; Al-Khatib SM; Almendral J; Aguinaga L; Berger RD; Cuesta A; Daubert JP; Dubner S; Ellenbogen KA; Estes NA; Fenelon G; Garcia FC; Gasparini M; Haines DE; Healey JS; Hurtwitz JL; Keegan R; Kolb C; Kuck KH; Marinskis G; Martinelli M; Mcguire M; Molina LG; Okumura K; Proclemer A; Russo AM; Singh JP; Swerdlow CD; Teo WS; Uribe W; Viskin S; Wang CC; Zhang S;
    Europace; 2016 Feb; 18(2):159-83. PubMed ID: 26585598
    [No Abstract]   [Full Text] [Related]  

  • 10. 2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients.
    Shah MJ; Silka MJ; Silva JNA; Balaji S; Beach CM; Benjamin MN; Berul CI; Cannon B; Cecchin F; Cohen MI; Dalal AS; Dechert BE; Foster A; Gebauer R; Gonzalez Corcia MC; Kannankeril PJ; Karpawich PP; Kim JJ; Krishna MR; Kubuš P; LaPage MJ; Mah DY; Malloy-Walton L; Miyazaki A; Motonaga KS; Niu MC; Olen M; Paul T; Rosenthal E; Saarel EV; Silvetti MS; Stephenson EA; Tan RB; Triedman J; Von Bergen NH; Wackel PL;
    Cardiol Young; 2021 Nov; 31(11):1738-1769. PubMed ID: 34338183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients.
    ; Shah MJ; Silka MJ; Silva JNA; Balaji S; Beach CM; Benjamin MN; Berul CI; Cannon B; Cecchin F; Cohen MI; Dalal AS; Dechert BE; Foster A; Gebauer R; Gonzalez Corcia MC; Kannankeril PJ; Karpawich PP; Kim JJ; Krishna MR; Kubuš P; LaPage MJ; Mah DY; Malloy-Walton L; Miyazaki A; Motonaga KS; Niu MC; Olen M; Paul T; Rosenthal E; Saarel EV; Silvetti MS; Stephenson EA; Tan RB; Triedman J; Bergen NHV; Wackel PL
    Heart Rhythm; 2021 Nov; 18(11):1888-1924. PubMed ID: 34363988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2021 PACES expert consensus statement on the indications and management of cardiovascular implantable electronic devices in pediatric patients.
    ; Shah MJ; Silka MJ; Avari Silva JN; Balaji S; Beach CM; Benjamin MN; Berul CI; Cannon B; Cecchin F; Cohen MI; Dalal AS; Dechert BE; Foster A; Gebauer R; Gonzalez Corcia MC; Kannankeril PJ; Karpawich PP; Kim JJ; Krishna MR; Kubuš P; LaPage MJ; Mah DY; Malloy-Walton L; Miyazaki A; Motonaga KS; Niu MC; Olen M; Paul T; Rosenthal E; Saarel EV; Silvetti MS; Stephenson EA; Tan RB; Triedman J; Von Bergen NH; Wackel PL;
    Indian Pacing Electrophysiol J; 2021; 21(6):367-393. PubMed ID: 34333141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of supraventricular arrhythmias on the outcomes of guideline-compliant implantable cardioverter defibrillator programming.
    Teerawongsakul P; Ananwattanasuk T; Chokesuwattanaskul R; Shah M; Lathkar-Pradhan S; Barham W; Oral H; Thakur RK; Jongnarangsin K; Tanawuttiwat T
    J Cardiovasc Electrophysiol; 2024 Apr; 35(4):794-801. PubMed ID: 38384108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term prognosis in patients with Brugada syndrome based on Class II indication for implantable cardioverter-defibrillator in the HRS/EHRA/APHRS Expert Consensus Statement: multicenter study in Japan.
    Takagi M; Sekiguchi Y; Yokoyama Y; Aihara N; Hiraoka M; Aonuma K;
    Heart Rhythm; 2014 Oct; 11(10):1716-20. PubMed ID: 24981871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal Implantable Cardioverter Defibrillator Programming.
    Shah BK
    Cardiol Rev; 2017; 25(1):30-35. PubMed ID: 27922468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interruption of Pacing Following Nonsustained Ventricular Tachycardia in an AAI Programmed Implantable Cardioverter Defibrillator.
    Egan P; Wilkoff BL; Tchou P
    Pacing Clin Electrophysiol; 2015 Sep; 38(9):1082-90. PubMed ID: 26010870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wilkoff BL, et al. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
    Europace; 2017 Apr; 19(4):580. PubMed ID: 28431075
    [No Abstract]   [Full Text] [Related]  

  • 18. Current implantable cardioverter-defibrillator programming in Europe: the results of the European Heart Rhythm Association survey.
    Proclemer A; Grazia Bongiorni M; Etsner H; Todd D; Sciaraffia E; Blomström-Lundqvist C;
    Europace; 2014 Jun; 16(6):935-8. PubMed ID: 24864305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure to Treat Life-Threatening Ventricular Tachyarrhythmias in Contemporary Implantable Cardioverter-Defibrillators: Implications for Strategic Programming.
    Thøgersen AM; Larsen JM; Johansen JB; Abedin M; Swerdlow CD
    Circ Arrhythm Electrophysiol; 2017 Sep; 10(9):e005305. PubMed ID: 28916511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defibrillators: Selecting the Right Device for the Right Patient.
    Al-Khatib SM; Friedman P; Ellenbogen KA
    Circulation; 2016 Nov; 134(18):1390-1404. PubMed ID: 27799257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.